TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- PMID: 23838947
- DOI: 10.1093/jac/dkt275
TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
Abstract
Objectives: Sulbactam is well known to have clinically relevant intrinsic activity against Acinetobacter baumannii. Although secondary resistance to this drug has long been reported in acinetobacters, virtually nothing is known about its molecular basis. The aim of this study was to test the hypothesis that β-lactamase TEM-1 is responsible for sulbactam resistance in A. baumannii.
Methods: Seventeen clinical strains of A. baumannii were selected to represent different combinations of quantitative susceptibilities to sulbactam and molecular typing characteristics. The strains were screened by PCR for the presence of the blaTEM-1 gene and its variants. Amplicons encompassing the blaTEM genes, including their promoters, were sequenced. The expression and copy number of the blaTEM genes were assessed using semi-quantitative real-time PCR. Transfer of the blaTEM-1 gene into a susceptible A. baumannii strain was achieved by electroporation.
Results: Six strains were negative for the blaTEM gene and had sulbactam MICs of 0.5-1.0 mg/L, 10 strains harboured blaTEM-1 and showed MICs ≥ 8.0 mg/L, except for one strain with an MIC of 2 mg/L, while the remaining strain carried blaTEM-19 and had an MIC of 1 mg/L. The level of blaTEM-1 expression positively correlated with the MICs of sulbactam (r = 0.92). Promoter P4 was linked to the blaTEM gene in all strains except for a P3-carrying strain (an MIC of 2 mg/L). Transformation of the susceptible A. baumannii strain with blaTEM-1 resulted in a 64-fold increase in sulbactam MIC and in resistance to ticarcillin and piperacillin, but no change in susceptibility to broad-spectrum generation cephalosporins, aztreonam or carbapenems.
Conclusions: The results presented suggest that TEM-1 represents a clinically relevant mechanism of sulbactam resistance in A. baumannii.
Keywords: gene expression; mechanisms of resistance; multidrug resistance; transformation.
Similar articles
-
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.Int J Antimicrob Agents. 2010 Apr;35(4):382-6. doi: 10.1016/j.ijantimicag.2009.12.009. Epub 2010 Feb 6. Int J Antimicrob Agents. 2010. PMID: 20138741
-
[Investigation of the frequency and distribution of beta-lactamase genes in the clinical isolates of Acinetobacter baumannii collected from different regions of Turkey: a multicenter study].Mikrobiyol Bul. 2016 Oct;50(4):511-521. doi: 10.5578/mb.29176. Mikrobiyol Bul. 2016. PMID: 28124956 Turkish.
-
Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.Clin Microbiol Infect. 2005 Jan;11(1):24-30. doi: 10.1111/j.1469-0691.2004.01015.x. Clin Microbiol Infect. 2005. PMID: 15649300
-
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Expert Rev Anti Infect Ther. 2013 Jun;11(6):571-83. doi: 10.1586/eri.13.38. Expert Rev Anti Infect Ther. 2013. PMID: 23750729 Review.
-
The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex.Clin Infect Dis. 2023 May 1;76(Suppl 2):S202-S209. doi: 10.1093/cid/ciad096. Clin Infect Dis. 2023. PMID: 37125469 Free PMC article. Review.
Cited by
-
Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.PLoS One. 2016 May 25;11(5):e0156237. doi: 10.1371/journal.pone.0156237. eCollection 2016. PLoS One. 2016. PMID: 27223476 Free PMC article.
-
New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species.Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02480-17. doi: 10.1128/AAC.02480-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29339383 Free PMC article.
-
Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.Semin Respir Crit Care Med. 2015 Feb;36(1):85-98. doi: 10.1055/s-0034-1398388. Epub 2015 Feb 2. Semin Respir Crit Care Med. 2015. PMID: 25643273 Free PMC article. Review.
-
OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01676-18. doi: 10.1128/AAC.01676-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30348663 Free PMC article. No abstract available.
-
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.Clin Infect Dis. 2023 May 1;76(Suppl 2):S179-S193. doi: 10.1093/cid/ciad094. Clin Infect Dis. 2023. PMID: 37125467 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous